Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.532 USD | +1.51% | -27.11% | -57.27% |
Apr. 16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.78M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.31
x | P/E ratio 2025 * |
-0.46
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 5.3% |
Latest transcript on Windtree Therapeutics, Inc.
1 day | -11.42% | ||
1 week | -28.64% | ||
Current month | -14.47% | ||
1 month | -15.90% | ||
3 months | -40.16% | ||
6 months | -74.12% | ||
Current year | -57.89% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 5.532 | +1.51% | 34 504 |
24-04-22 | 5.45 | -11.42% | 197,945 |
24-04-19 | 6.152 | +0.59% | 27,436 |
24-04-18 | 6.116 | -15.32% | 100,053 |
24-04-17 | 7.223 | -4.79% | 6,003 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.89% | 2.78M | |
-0.02% | 42.11B | |
+44.93% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- WINT Stock